A method of reducing weight gain associated with olanzapine treatment in a human subject, by orally administering to an olanzapine-treated subject betahistine or a salt thereof, is disclosed.
Web www.patentalert.com
< Compounds, their preparation and use
< Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatment
> Obesity controlling method
> Methods, systems, and software for identifying functional biomolecules
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT